BioCatalyst

Leniolisib — catalyst calendar

2 verified catalyst event(s) referencing Leniolisib, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 3mo
ESTIMATED
 READOUT
Leniolisib for Immune Dysregulation in CVID
Phase 2 · Common Variable Immunodeficiency (CVID)
 Pharming Technologies B.V. Leniolisib ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-11 (month)
in 4mo
ESTIMATED
 READOUT
Leniolisib for Immune Dysregulation in PIDs
Phase 2 · Primary Immunodeficiency Disorders (PIDs)
 Pharming Technologies B.V. Leniolisib ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.